ConductScience.org, home

Paper7007597

The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis.

Marks MI. J Pediatr, 1981. Cited by 157 papers, by iCite.

Cite this record

ConductScience Library. The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis. Papers, record 7007597. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7007597

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis.
PubMed
Journal
J Pediatr
PubMed
Year
1981
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
157
iCite
Relative citation ratio, by iCite
9.04
iCite
Revised in PubMed
2019-06-30
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marks MIM I

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cystic FibrosisMajor topic
Respiratory Tract InfectionsMajor topic
Animals
Anti-Bacterial Agents
Child
Humans
Immunologic Techniques
Pneumonia
Pseudomonas Infections
Rabbits
Rats
Sputum
Staphylococcal Infections

Source PubMed

Download CSV of topics

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 157 citations.

PMIDTitleJournalYearIn PapersSource
11706924Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.Paediatr Drugs2001https://conductscience.org/library/papers/11706924PubMed
8181493New perspectives in understanding and management of the respiratory disease in cystic fibrosis.Eur J Pediatr1994https://conductscience.org/library/papers/8181493PubMed
8067743Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8067743PubMed
7649191Correlation between activity of beta-lactam agents in vitro and bacteriological outcome in acute pulmonary exacerbations of cystic fibrosis.Eur J Clin Microbiol Infect Dis1995https://conductscience.org/library/papers/7649191PubMed
7094939Sputum penetration of fusidic acid in patients with cystic fibrosis.Eur J Pediatr1982https://conductscience.org/library/papers/7094939PubMed
6981383Pseudomonas infection, allergy, and cystic fibrosis.Arch Dis Child1982https://conductscience.org/library/papers/6981383PubMed
6810763Circulating soluble immune complexes containing pseudomonas antigens in cystic fibrosis.Arch Dis Child1982https://conductscience.org/library/papers/6810763PubMed
6756730Functional activity of peripheral mononuclear cells in cystic fibrosis: antibodies and plaque formation.Clin Exp Immunol1982https://conductscience.org/library/papers/6756730PubMed
6732230Azlocillin pharmacokinetics in patients with cystic fibrosis.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6732230PubMed
6426075Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis.Thorax1984https://conductscience.org/library/papers/6426075PubMed
4083865Pharmacokinetics and dosage requirements of netilmicin in cystic fibrosis patients.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/4083865PubMed
3859245Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/3859245PubMed
3780832Pharmacokinetics of amikacin in cystic fibrosis: a study of bronchial diffusion.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3780832PubMed
3522911Viral infection in cystic fibrosis.J R Soc Med1986https://conductscience.org/library/papers/3522911PubMed
3497170Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis.J Clin Microbiol1987https://conductscience.org/library/papers/3497170PubMed
3311531Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.Clin Pharmacokinet1987https://conductscience.org/library/papers/3311531PubMed
3118820Prospective study of serum staphylococcal antibodies in cystic fibrosis.Arch Dis Child1987https://conductscience.org/library/papers/3118820PubMed
3117842Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.J Clin Microbiol1987https://conductscience.org/library/papers/3117842PubMed
3115896Role of sialic acid in saliva-mediated aggregation of Pseudomonas aeruginosa isolated from cystic fibrosis patients.Infect Immun1987https://conductscience.org/library/papers/3115896PubMed
3093524Variation and adaptation of Pseudomonas aeruginosa toxicity to HeLa cells and fibroblasts.J Clin Microbiol1986https://conductscience.org/library/papers/3093524PubMed

See all 32 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7007597

GET https://conductscience.org/api/papers/v1/7007597/cited_by?page=2